So. San Francisco, Calif., Nov. 23 /PRNewswire-FirstCall/ -- Monogram Biosciences, Inc. announced today that William D. Young, CEO and Chairman, is scheduled to present a corporate overview at the Lazard Capital Markets 2005 Life Sciences Conference on Tuesday, November 29, 2005 at 2:30 p.m. Eastern Time at the Palace Hotel in New York City.
To access the live audio broadcast or the subsequent archived recording log on to http://www.monogrambio.com/ and go to the investor relations section to the link provided on the Event Calendar page. The archived version of the webcast will be available online for one month.
About Monogram Biosciences, Inc.
Monogram, formerly ViroLogic, Inc., is advancing individualized medicine by discovering, developing and marketing innovative products to guide and improve treatment of serious infectious diseases and cancer. The Company's products are designed to help doctors optimize treatment regimens for their patients that lead to better outcomes and reduced costs. The Company's technology is also being used by numerous biopharmaceutical companies to develop new and improved antiviral therapeutics and vaccines as well as targeted cancer therapeutics. More information about the Company and its technology can be found on its web site at www.monogrambio.com.
Monogram Biosciences, Inc.CONTACT: Alfred G. Merriweather, Chief Financial Officer of MonogramBiosciences, Inc., +1-650-624-4576, or amerriweather@monogrambio.com
Web site: http://www.monogrambio.com//
